The US Food and Drug Administration (USFDA) conducted inspection at Jarod-based solid oral formulation facility.

[29,30,31] Edema will diminish upon conversion from a dihydropyridine CCB to a nondihydropyridine CCB such as verapamil or diltiazem. In addition, the newer, third-generation dihydropyridine CCBs ...

Juan Benezet-Mazuecos, M.D.; José M. Rubio, M.D.; PH.D., Jerónimo Farré , M.D., PH.D.; Miguel Á. Quinñones, M.D.; Pepa Sanchez-Borque, M.D.; Ester Macía, M.D ...